Geron | GERN - Pre Tax Profit


Geron reported $-3.64M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Amgen USD 1.51B 2.41B Dec/2025
Bio Techne USD 50.78M 34.21M Dec/2025
Cassava Sciences USD -10.81M 33.41M Sep/2025
Cytokinetics USD -206.03M 23M Mar/2026
Esperion Therapeutics USD 63.67M 95M Dec/2025
Exelixis USD 267.69M 15M Mar/2026
Genmab DKK 55M 427M Dec/2025
Geron USD -3.64M 27.5M Mar/2026
Gilead Sciences USD 2.08B 1.56B Dec/2025
Incyte USD 343.6M 46.34M Mar/2026
MacroGenics USD -36.77M 21.84M Mar/2026
Novartis USD 3.84B 802M Mar/2026
Novavax USD 17.9M 220.94M Dec/2025